Quadrille Capital

Activity from announced rounds

Activity in this selectionUnited States · Oct 16, 2026 · Sep 17, 2026
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$130M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1

By primary sector

Biotech1
Cybersecurity1

By country

United States2

Rounds

2 in this selection
Reco

Cybersecurity software that helps security teams discover, govern and secure SaaS applications, identities and AI agents.

$55MSeries B extension
Participant
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant